Dajing Xia

1.8k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Dajing Xia is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Dajing Xia has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Dajing Xia's work include Immunotherapy and Immune Responses (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Heat shock proteins research (3 papers). Dajing Xia is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Heat shock proteins research (3 papers). Dajing Xia collaborates with scholars based in China, Macao and United States. Dajing Xia's co-authors include Shujun Xie, Xue Zhang, Yangyang Liu, Li Zhang, Mingzhu Zheng, Zhexu Chi, Di Wang, Linrong Lu, Chuansheng Guo and Jinhua Zhang and has published in prestigious journals such as Immunity, Journal of Hazardous Materials and Oncogene.

In The Last Decade

Dajing Xia

25 papers receiving 1.1k citations

Hit Papers

Bile Acids Control Inflammation and Metabolic Disorder th... 2016 2026 2019 2022 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dajing Xia China 12 627 281 213 189 159 28 1.2k
Shujun Xie China 13 642 1.0× 246 0.9× 228 1.1× 184 1.0× 80 0.5× 22 1.2k
Jiaxiang Zhang China 21 504 0.8× 362 1.3× 97 0.5× 132 0.7× 156 1.0× 92 1.4k
Jun Zou China 24 560 0.9× 207 0.7× 177 0.8× 351 1.9× 315 2.0× 52 1.5k
Sanjeev Noel United States 23 556 0.9× 427 1.5× 126 0.6× 112 0.6× 107 0.7× 48 1.5k
Palash Mandal India 19 634 1.0× 324 1.2× 222 1.0× 514 2.7× 188 1.2× 79 1.6k
Adebowale Adeyemi United States 7 593 0.9× 218 0.8× 246 1.2× 418 2.2× 164 1.0× 14 1.1k
Zhen Yu China 21 645 1.0× 797 2.8× 219 1.0× 143 0.8× 87 0.5× 48 1.8k
Daniel R. Prows United States 23 670 1.1× 197 0.7× 176 0.8× 200 1.1× 188 1.2× 56 1.6k
Egon Demetz Austria 22 486 0.8× 193 0.7× 105 0.5× 168 0.9× 118 0.7× 42 1.6k
Zhexu Chi China 13 1.1k 1.8× 487 1.7× 218 1.0× 235 1.2× 123 0.8× 17 1.7k

Countries citing papers authored by Dajing Xia

Since Specialization
Citations

This map shows the geographic impact of Dajing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dajing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dajing Xia more than expected).

Fields of papers citing papers by Dajing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dajing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dajing Xia. The network helps show where Dajing Xia may publish in the future.

Co-authorship network of co-authors of Dajing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Dajing Xia. A scholar is included among the top collaborators of Dajing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dajing Xia. Dajing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chunming, Ze-Kun Liu, Jie Luo, et al.. (2024). MiR-204 regulates autophagy and cell viability by targeting BDNF and inhibiting the NTRK2-dependent PI3K/Akt/mTOR pathway in a human granulosa cell line exposed to bisphenol A. Ecotoxicology and Environmental Safety. 287. 117304–117304. 2 indexed citations
2.
Li, Chunming, et al.. (2024). Exposure to perfluorodecanoic acid impairs follicular development via inducing granulosa cell necroptosis. Ecotoxicology and Environmental Safety. 287. 117268–117268. 3 indexed citations
3.
Tang, Song, Zheng Fang, Kelie Chen, et al.. (2024). Novel scoring system incorporating lipoproteins to predict outcomes of epithelial ovarian cancer patients. International Journal of Gynecological Cancer. 35(7). 101855–101855.
4.
Chen, Kelie, Shengchao Wang, Fang Zheng, et al.. (2023). MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage. Oncogene. 42(18). 1438–1452. 9 indexed citations
5.
Zheng, Fang, Kelie Chen, Yu Shi, et al.. (2023). PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway. Journal of Experimental & Clinical Cancer Research. 42(1). 295–295. 13 indexed citations
6.
Chen, Wenhan, Sinan Xu, Kelie Chen, et al.. (2023). Low dose PFDA induces DNA damage and DNA repair inhibition by promoting nuclear cGAS accumulation in ovarian epithelial cells. Ecotoxicology and Environmental Safety. 265. 115503–115503. 12 indexed citations
7.
Yuan, Xiaoyu, Kelie Chen, Fang Zheng, et al.. (2023). Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling. Journal of Hazardous Materials. 452. 131288–131288. 37 indexed citations
8.
Niu, Yuequn, Kelie Chen, Fang Zheng, et al.. (2022). Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis. Cancer Immunology Research. 11(2). 199–216. 34 indexed citations
10.
Huang, Bo, et al.. (2018). Ibrutinib Exacerbates Bleomycin-Induced Pulmonary Fibrosis via Promoting Inflammation. Inflammation. 41(3). 904–913. 12 indexed citations
11.
Xu, Jinming, Ye Yao, Han Wu, et al.. (2016). Association between markers of glucose metabolism and risk of colorectal cancer. BMJ Open. 6(6). e011430–e011430. 70 indexed citations
12.
Guo, Chuansheng, Shujun Xie, Zhexu Chi, et al.. (2016). Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity. 45(4). 802–816. 635 indexed citations breakdown →
13.
Yao, Ye, Yihua Wu, Jinming Xu, et al.. (2016). Association between dietary carbohydrate intake, glycemic index and glycemic load, and risk of gastric cancer. European Journal of Nutrition. 56(3). 1169–1177. 25 indexed citations
14.
Huang, Fang, Qiaoyun Liu, Shujun Xie, et al.. (2016). Cypermethrin Induces Macrophages Death through Cell Cycle Arrest and Oxidative Stress-Mediated JNK/ERK Signaling Regulated Apoptosis. International Journal of Molecular Sciences. 17(6). 885–885. 67 indexed citations
15.
Xia, Dajing. (2013). Comparison of disinfectant-resistant genes in Escherichia coli between hospital-acquired infection and community-acquired infection. Zhongguo weishengtaixue zazhi. 2 indexed citations
16.
Wang, Huaying, et al.. (2012). Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. International Immunopharmacology. 14(4). 504–512. 59 indexed citations
17.
Huang, Changxin, Jiangang Zhao, Zhaoyang Li, et al.. (2010). Multi-chaperone-peptide-rich mixture from colo-carcinoma cells elicits potent anticancer immunity. Cancer Epidemiology. 34(4). 494–500. 8 indexed citations
18.
Huang, Changxin, Hai Yu, Qingqing Wang, et al.. (2005). A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy. Immunology Letters. 101(1). 71–80. 5 indexed citations
19.
Wang, Baomei, Nan Li, Yanfeng Wu, et al.. (2004). HuBMSC-MCP, a novel member of mitochondrial carrier superfamily, enhances dendritic cell endocytosis. Biochemical and Biophysical Research Communications. 314(1). 292–300. 9 indexed citations
20.
Jiang, Yingming, Tao Wan, Guoyou Chen, et al.. (2003). DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells. Journal of Cancer Research and Clinical Oncology. 129(1). 57–64. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026